Clinical Trial

Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

Name: Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer — clinical trial record (NCT06791941)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Multicenter, non-interventional, retrospective/prospective study of a biological nature, on patients affected by head and neck tumors, for which the collection and use of tissue samples is planned for the study of the mutational profile, the transcriptional profile and the proteomic profile.

Trial Details

NCT Number	NCT06791941
Lead Sponsor	Regina Elena Cancer Institute
Conditions	Head and Neck Tumors
Enrollment	18 participants
Start Date	2024-03-07
Primary Completion	2029-03-07 (estimated)
Study Completion	2029-03-07 (estimated)
Updated on ClinicalTrials.gov	2025-01-24